Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Mania Bipolar Disorder”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Large-scale testing (Phase 3)Study completedNCT00299715
What this trial is testing

Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Large-scale testing (Phase 3)Study completedNCT00259272
What this trial is testing

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Who this might be right for
Bipolar Disorder I or II
Eli Lilly and Company 141
Post-approval studies (Phase 4)Study completedNCT00394095
What this trial is testing

Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine

Who this might be right for
Bipolar DisorderWeight Gain
University of Cincinnati 31
Large-scale testing (Phase 3)Study completedNCT00035230
What this trial is testing

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 338
Post-approval studies (Phase 4)Study completedNCT00190892
What this trial is testing

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 120
Large-scale testing (Phase 3)Ended earlyNCT01122927
What this trial is testing

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Who this might be right for
Adolescent SchizophreniaChild or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Otsuka Pharmaceutical Development & Commercialization, Inc. 524
Post-approval studies (Phase 4)Study completedNCT01195363
What this trial is testing

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder

Who this might be right for
Bipolar Disorder
The University of Texas Health Science Center at San Antonio 28
Large-scale testing (Phase 3)Study completedNCT03573297
What this trial is testing

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Who this might be right for
Bipolar I DisorderManiaDepression
AbbVie 901
Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing

Aripiprazole Open-Label, Safety and Tolerability Study

Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325
Post-approval studies (Phase 4)Study completedNCT00350857
What this trial is testing

The Young Adult and Pediatric Bipolar Study

Who this might be right for
Bipolar I Disorder
Validus Pharmaceuticals 161
Large-scale testing (Phase 3)Study completedNCT01349907
What this trial is testing

Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)

Who this might be right for
Bipolar Disorder
Organon and Co 322
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Post-approval studies (Phase 4)Study completedNCT00191997
What this trial is testing

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 180
Large-scale testing (Phase 3)Study completedNCT00145470
What this trial is testing

12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)

Who this might be right for
Bipolar Disorder
Organon and Co 326
Large-scale testing (Phase 3)Study completedNCT00764478
What this trial is testing

Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)

Who this might be right for
Bipolar 1 Disorder
Organon and Co 367
Large-scale testing (Phase 3)Study completedNCT00280566
What this trial is testing

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Who this might be right for
Bipolar ManiaBipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 584
Not applicableStudy completedNCT00690248
What this trial is testing

Depressive Symptoms in Acute Manic Episode

Who this might be right for
Bipolar Disorder
AstraZeneca 250
Large-scale testing (Phase 3)Study completedNCT03259555
What this trial is testing

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I DisorderManic Episode
Otsuka Pharmaceutical Development & Commercialization, Inc. 322
Large-scale testing (Phase 3)Study completedNCT01602510
What this trial is testing

Lamotrigine Phase III Study in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
GlaxoSmithKline 265
Large-scale testing (Phase 3)WithdrawnNCT01117220
What this trial is testing

Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Load More Results